China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A real-world study based on TFV plasma concentration stratification to evaluate the efficacy and safety of TMF rescue therapy in patients with chronic hepatitis B and low-level viremia after prior treatment.'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130170
Registration Time: 2026/08/17
Type: Observational study
Primary Sponsor: The Third Affiliated Hospital of Sun Yat-sen University (Sun Yat-sen University Hospital of Hepatology)
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=330286
Published by HT Digital Content Services with permission from ...